1. Home
  2. FCNCA vs BNTX Comparison

FCNCA vs BNTX Comparison

Compare FCNCA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCNCA
  • BNTX
  • Stock Information
  • Founded
  • FCNCA 1898
  • BNTX 2008
  • Country
  • FCNCA United States
  • BNTX Germany
  • Employees
  • FCNCA N/A
  • BNTX N/A
  • Industry
  • FCNCA Major Banks
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FCNCA Finance
  • BNTX Health Care
  • Exchange
  • FCNCA Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • FCNCA 25.4B
  • BNTX 25.0B
  • IPO Year
  • FCNCA N/A
  • BNTX 2019
  • Fundamental
  • Price
  • FCNCA $1,840.25
  • BNTX $95.81
  • Analyst Decision
  • FCNCA Buy
  • BNTX Strong Buy
  • Analyst Count
  • FCNCA 9
  • BNTX 18
  • Target Price
  • FCNCA $2,420.44
  • BNTX $142.27
  • AVG Volume (30 Days)
  • FCNCA 85.3K
  • BNTX 896.4K
  • Earning Date
  • FCNCA 07-24-2025
  • BNTX 05-05-2025
  • Dividend Yield
  • FCNCA 0.42%
  • BNTX N/A
  • EPS Growth
  • FCNCA N/A
  • BNTX N/A
  • EPS
  • FCNCA 175.01
  • BNTX N/A
  • Revenue
  • FCNCA $9,091,000,000.00
  • BNTX $2,968,331,171.00
  • Revenue This Year
  • FCNCA N/A
  • BNTX N/A
  • Revenue Next Year
  • FCNCA $2.30
  • BNTX $9.07
  • P/E Ratio
  • FCNCA $10.56
  • BNTX N/A
  • Revenue Growth
  • FCNCA N/A
  • BNTX 0.61
  • 52 Week Low
  • FCNCA $1,473.62
  • BNTX $76.53
  • 52 Week High
  • FCNCA $2,412.93
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • FCNCA 45.43
  • BNTX 46.34
  • Support Level
  • FCNCA $1,800.46
  • BNTX $96.38
  • Resistance Level
  • FCNCA $1,856.78
  • BNTX $100.48
  • Average True Range (ATR)
  • FCNCA 32.55
  • BNTX 3.44
  • MACD
  • FCNCA -12.63
  • BNTX 0.24
  • Stochastic Oscillator
  • FCNCA 6.47
  • BNTX 40.84

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: